Last update 01 Nov 2024

CysLT1 x mGluR2

Basic Info

Related Targets
CysLT1mGluR2

Related

1
Drugs associated with CysLT1 x mGluR2
LY-2300559
Target
CysLT1 x mGluR2
Mechanism
CysLT1 antagonists [+1]
Active Org.-
Originator Org.
Eli Lilly & Co.Eli Lilly & Co.
Active Indication-
Inactive Indication
Migraine Disorders
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CysLT1 x mGluR2
NCT01184508 / TerminatedPhase 2
A Randomized, Double-Blind, Placebo Controlled Proof of Concept Study of LY2300559 in Patients With Migraine
100 Clinical Results associated with CysLT1 x mGluR2
Login to view more data
100 Translational Medicine associated with CysLT1 x mGluR2
Login to view more data
0 Patents (Medical) associated with CysLT1 x mGluR2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free